Updated

AmerisourceBergen to pay $625 million in U.S. civil fraud settlement

Oct 1, 2018

By Jonathan Stempel NEW YORK (Reuters) – AmerisourceBergen Corp, one of the largest U.S. drug wholesalers, will pay $625 million to resolve civil fraud charges over the sale of syringes containing drugs for cancer...

DaVita unit to pay $270 million to resolve Medicare payments probe

Oct 1, 2018

By Nate Raymond (Reuters) – A medical care unit of DaVita Inc <DVA.N> has agreed to...

WHO plays down risk to Indian children from tainted polio vaccine

Oct 1, 2018

MUMBAI (Reuters) – The World Health Organisation (WHO) said on Monday that there was minimal...

Antares Pharma’s testosterone drug gets FDA approval

Oct 1, 2018

By Aakash B (Reuters) – The U.S. Food and Drug Administration on Monday approved Antares Pharma Inc’s injectable drug to treat low testosterone levels in men, the company said, nearly a year after being rejected. The...

Insmed’s treatment-resistant lung disease drug gets FDA approval

Sep 28, 2018

By Saumya Joseph (Reuters) – The U.S. Food and Drug Administration on Friday approved Insmed Inc’s lead drug to treat a rare, chronic lung disease, making it the first approved treatment in the United States for the...

Sanofi, Regeneron skin cancer drug gets FDA nod

Sep 28, 2018

(Reuters) – Sanofi SA said on Friday its skin cancer drug, made in partnership with...

U.S. judge dismisses Teva lawsuits against Lilly on migraine drug

Sep 27, 2018

BOSTON (Reuters) – A federal judge on Thursday dismissed a pair of patent infringement...

Pfizer’s lung cancer drug gets FDA approval

Sep 27, 2018

(Reuters) – Pfizer Inc said on Thursday that its once-daily oral drug to treat a rare form...

Older people with more friends do better at preventive health

Sep 27, 2018

By Lisa Rapaport (Reuters Health) – Older adults with bigger social networks of family members and close friends may be better at staying on top of recommended preventive health screenings and checkups than their more...

Novartis strikes deal with Chinese firm to make Kymriah

Sep 27, 2018

ZURICH (Reuters) – Novartis has enlisted Chinese manufacturer Cellular Biomedicine (CBMG) to...

Early approval of Alnylam’s gene-silencing drug in question

Sep 27, 2018

By Saumya Joseph and Manojna Maddipatla (Reuters) – Alnylam Pharmaceuticals Inc said on Thursday it might have to hold off on plans to seek an accelerated approval for its gene-silencing drug, which showed effectiveness in...

Aetna, seeking antitrust nod, sells Medicare drug business to WellCare

Sep 27, 2018

By Caroline Humer (Reuters) – Health insurer Aetna Inc <AET.N> said on Thursday it...

Heavy drinkers and teetotalers alike may have heightened dementia risk

Sep 26, 2018

By Lisa Rapaport (Reuters Health) – Middle-aged adults who avoid alcohol altogether, and...

Defibrillator vest fails test because many heart attack survivors wouldn’t wear it

Sep 26, 2018

By Gene Emery (Reuters Health) – Patients who have just survived a heart attack and...

Judicial bypass process for abortion in Texas causes harm, researchers say

Sep 26, 2018

(In paragraph 2, changes “2016” to “2000” and in paragraph 3, corrects researcher’s affiliation.) By Carolyn Crist (Reuters Health) – The judicial bypass process for abortion in Texas could be...

UK healthcare worker contracts rare monkeypox virus in third case

Sep 26, 2018

By Kate Kelland LONDON (Reuters) – A health worker in northern England has become the third person in Britain to contract a rare illness caused by a monkeypox virus after caring for a patient infected with the disease...